Friday, November 18, 2011

Clinical presentation and outcome of patients with intradural spinal cord tumours

Publication year: 2011
Source: Journal of Clinical Neuroscience, Available online 17 November 2011
Mithun Nambiar, Bhadrakant Kavar
We aimed to retrospectively investigate the clinical presentation and outcome of surgical intervention of patients with intradural spinal cord tumours (IDSCT), and to assess the predictors of surgical outcome. A total of 109 patients with IDSCT (57 males and 52 females) (130 admissions; mean age, 45.9 years; range, 14–89 years) underwent surgery between 1 January 1994 and 30 June 2009 at The Royal Melbourne Hospital. Ninety per cent of tumours were classified as low grade. Pain was the most common symptom at presentation (60%) and the mean duration of symptoms was 37.8 weeks (0–4 years). Total resection was achieved in 72.3% of patients with IDSCT. An extramedullary location was the strongest predictor of greater extent of tumour resection (odds ratio [OR] = 4.367, 95% confidence interval [CI] = 1.876–10.204,p = 0.001), whereas a rostral location was also a significant predictor of greater resection (OR = 1.393, 95% CI = 1.014–1.908,p = 0.040). The surgical mortality rate was 0.92%. A good pre-operative clinical grade was the strongest predictor of a positive post-operative neurological status at discharge for IDSCT (OR = 7.382, 95% CI = 4.575–11.912,p < 0.001). The mean follow-up was 37.9 months (16 days–165 months). A good post-operative clinical grade was the most significant predictor of a positive neurological outcome at short-term follow-up (OR = 9.953, 95% CI = 4.941–20.051,p < 0.001), while a good pre-morbid clinical grade was the most significant predictor of a positive outcome at long-term follow-up (OR = 9.498, 95% CI = 2.780–32.451,p < 0.001). We concluded that surgical outcome was influenced by pre-morbid, pre-operative and post-operative clinical grades, the extent of resection, tumour grade and tumour location with respect to the spinal parenchyma. Surgical intervention has a high success rate for tumour control and we recommend total resection where possible.





No comments:

Post a Comment